AGLE - Aeglea BioTherapeutics' (AGLE) CEO Anthony Quinn on Q4 2018 Results - Earnings Call Transcript
Aeglea BioTherapeutics (AGLE)
Q4 2018 Earnings Conference Call
March 7, 2019 04:30 pm ET
Company Participants
David Calusdian - IR, Sharon Merrill Associates
Anthony Quinn - Chief Executive Officer
Charles York - Chief Financial Officer
Jim Wooldridge - Chief Medical Officer
Conference Call Participants
Josh Schimmer - Evercore ISI
Rajvindra Gill - Needham and Company
Matthew Cross - H.C. Wainwright
Presentation
Operator
Greetings and welcome to the Fourth Quarter 2018 Corporate Update and Earnings Call. And at this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator